When nucleotide-binding oligomerization domain-like receptors (NLRs) sense cytosolic-invading bacteria, they induce the formation of inflammasomes and initiate an innate immune response. In quiescent cells, inflammasome activity is tightly regulated to prevent excess inflammation and cell death. Many bacterial pathogens provoke inflammasome activity and induce inflammatory responses, including cell death, by delivering type III secreted effectors, the rod component flagellin, and toxins. Recent studies indicated that Shigella deploy multiple mechanisms to stimulate NLR inflammasomes through type III secretion during infection. Here, we show that Shigella induces rapid macrophage cell death by delivering the invasion plasmid antigen H7.8 (IpaH7.8) enzyme 3 (E3) ubiquitin ligase effector via the type III secretion system, thereby activating the NLR family pyrin domain-containing 3 (NLRP3) and NLR family CARD domain-containing 4 (NLRC4) inflammasomes and caspase-1 and leading to macrophage cell death in an IpaH7.8 E3 ligase-dependent manner. Mice infected with Shigella possessing IpaH7.8, but not with Shigella possessing an IpaH7.8 E3 ligase-null mutant, exhibited enhanced bacterial multiplication. We defined glomulin/flagellar-associated protein 68 (GLMN) as an IpaH7.8 target involved in IpaH7.8 E3 ligase-dependent inflammasome activation. This protein originally was identified through its association with glomuvenous malformations and more recently was described as a member of a Cullin ring ligase inhibitor. Modifying GLMN levels through overexpression or knockdown led to reduced or augmented inflammasome activation, respectively. Macrophages stimulated with lipopolysaccharide/ATP induced GLMN puncta that localized with the active form of caspase-1. Macrophages from GLMN +/− mice were more responsive to inflammasome activation than those from GLMN +/+ mice.
When nucleotide-binding oligomerization domain-like receptors (NLRs) sense cytosolic-invading bacteria, they induce the formation of inflammasomes and initiate an innate immune response. In quiescent cells, inflammasome activity is tightly regulated to prevent excess inflammation and cell death. Many bacterial pathogens provoke inflammasome activity and induce inflammatory responses, including cell death, by delivering type III secreted effectors, the rod component flagellin, and toxins. Recent studies indicated that Shigella deploy multiple mechanisms to stimulate NLR inflammasomes through type III secretion during infection. Here, we show that Shigella induces rapid macrophage cell death by delivering the invasion plasmid antigen H7.8 (IpaH7.8) enzyme 3 (E3) ubiquitin ligase effector via the type III secretion system, thereby activating the NLR family pyrin domain-containing 3 (NLRP3) and NLR family CARD domain-containing 4 (NLRC4) inflammasomes and caspase-1 and leading to macrophage cell death in an IpaH7.8 E3 ligase-dependent manner. Mice infected with Shigella possessing IpaH7.8, but not with Shigella possessing an IpaH7.8 E3 ligase-null mutant, exhibited enhanced bacterial multiplication. We defined glomulin/flagellar-associated protein 68 (GLMN) as an IpaH7.8 target involved in IpaH7.8 E3 ligase-dependent inflammasome activation. This protein originally was identified through its association with glomuvenous malformations and more recently was described as a member of a Cullin ring ligase inhibitor. Modifying GLMN levels through overexpression or knockdown led to reduced or augmented inflammasome activation, respectively. Macrophages stimulated with lipopolysaccharide/ATP induced GLMN puncta that localized with the active form of caspase-1. Macrophages from GLMN +/− mice were more responsive to inflammasome activation than those from GLMN +/+ mice.
Together, these results highlight a unique bacterial adaptation that hijacks inflammasome activation via interactions between IpaH7.8 and GLMN.
TTSS effector | pyroptosis I nflammasome activation is a key defense mechanism against bacterial infection that induces innate immune responses such as caspase-1 activation and inflammatory cell death (1) (2) (3) . Although the mechanisms through which various bacterial activities promote infection remain incompletely understood, some bacterial pathogens stimulate inflammasome activity by delivering cytotoxins, type III secretion (T3SS)-mediated effectors, T3SS components, flagellin, or cytotoxins to the host cell membrane and cytoplasm. These foreign components modify the host cellsurface architecture, induce membrane damage, subvert cell signaling, reorganize the actin cytoskeleton, and alter cell physiology (4) through interactions with various cytoplasmic receptors, e.g., nucleotide-binding oligomerization domain-like receptors (NLRs)-including NLRP1, NLR family CARD domain-containing 4 (NLRC4), NLR family pyrin domain-containing 3 (NLRP3), AIM2, IFI16, and RIG-1-as pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs) (2, 3, 5) . Upon recognition of these PAMPs and DAMPs, NLRs induce the assembly of inflammasomes, which are composed of NLR, apoptosis-associated speck-like protein (ASC), and inflammatory caspases such as caspase-1. Inflammasome assembly ultimately results in the extracellular release of IL-1β and IL-18 and induces inflammatory cell death (called "pyroptosis") (6). For example, NLRP3 senses membrane rupture that occurs during infection with Listeria monocytogenes, Shigella, Salmonella typhimurium, Staphylococcus aureus, Neisseria gonorrhoeae, and Chlamydia spp. and upon exposure to bacterial pore-forming toxins, leading to caspase-1 activation (7-10). NLRC4 detects L. monocytogenes and S.
Significance
Shigella modulates macrophage cell death by activating nucleotide-binding oligomerization domain-like receptor (NLR) inflammasome to secure its own dissemination. Here we report that Shigella invasion plasmid antigen H7.8 (IpaH7.8) plays a central role in inducing macrophage cell death via activation of NLR family pyrin domain-containing 3 and NLR family CARD domain-containing 4 inflammasomes in an IpaH7.8 enzyme 3 (E3) ligase-dependent manner. Importantly, an IpaH7.8-deficient mutant was unable to egress from macrophages efficiently, resulting in delayed bacterial multiplication. We identified glomulin-a member of the S-phase kinase-associated protein 1-F-box-like complex that originally was identified as a protein required for normal vascular development-as a target for IpaH7.8 E3 ligase-mediated polyubiquitination, which leads to NLR inflammasome activation. In vitro and in vivo studies confirmed that IpaH7.8-mediated glomulin degradation during Shigella infection activated NLR inflammasomes and promoted cell death.
typhimurium infection and stimulates caspase-1 activation (11) (12) (13) (14) . NLRC4 also senses flagellin and the T3SS rod components of Legionella pneumophila, Pseudomonas aeruginosa, Shigella, and S. typhimurium (11, (15) (16) (17) (18) (19) (20) and the T3SS needle components of Chromobacterium violaceum, S. typhimurium, enterohemorrhagic Escherichia coli, Burkholderia thailandensis, and Shigella (21). Therefore, NLR inflammasomes act as major cytoplasmic pattern-recognition receptors and as central platforms that transmit alarm signals to a variety of downstream innate immune systems.
Some bacterial pathogens, such as S. typhimurium (22) and Yersinia pseudotuberculosis (23) (24) (25) , can induce macrophage death after they have fully replicated, promoting the egress of bacteria from their replicative compartments and the subsequent dissemination of bacteria into new host cells. This causal relationship suggests that these pathogens may benefit from and exert control over host cell death and the inflammatory response. In the case of Shigella, the bacteria rapidly induce macrophage cell death at early stages of infection, which is accompanied by NLR inflammasome activation and inflammatory cell death through a T3SS-dependent mechanism (19, 22) . Previous studies indicated that during replication in macrophages, LPS, peptidoglycan, and T3SS rod or needle components of Shigella are recognized by the NLRC4 and NLRP3 inflammasomes (8, (19) (20) (21) . Interestingly, the mode through which NLRs recognize Shigella infections seems to vary across different infection conditions. At a low infectious dose [e.g., a multiplicity of infection (MOI) of [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , bacteria induce rapid NLRC4-caspase-1-dependent pyroptosis at 2-3 h postinfection through the recognition of the T3SS components or some uncharacterized T3SS-delivered substance(s) (19, 22) . However, at a high infectious dose (e.g., an MOI over 50) and at later time points (6 h postinfection), the bacteria induce NLRP3-dependent but caspase-1-independent necrosis-like cell death with inflammation (called "pyronecrosis") (8) . Because pyroptosis results in the release of intracellular contents, including proinflammatory cytokines and chemokines, and because, in the case of Shigella, macrophage death is a prerequisite for the subsequent infection of surrounding epithelial cells (19, 26) , it remains unclear whether Shigella-mediated rapid cell death is beneficial to the pathogen or to the host. Nevertheless, these studies strongly suggest that the bacteria deploy multiple mechanisms to manipulate macrophage cell-death pathways in a T3SS-dependent manner.
Shigella flexneri, e.g., the YSH6000 strain, possesses three invasion plasmid antigen H (ipaH) genes, ipaH9.8, ipaH7.8, and ipaH4.5, on a large virulence plasmid (27, 28) . These IpaH proteins, which originally were identified in the S. flexneri M90T strain (29, 30) , recently were found to act as enzyme 3 (E3) ubiquitin ligases (31) and were thus named "novel E3 ligases" (32) . The ipaH cognate genes are distributed among various Gram-negative bacterial pathogens, including Shigella, Salmonella, Yersinia, Edwardsiella ictaluri, Bradyrhizobium japonica, Rhizobium sp. strain NGR234, Pseudomonas putida, Pseudomonas entomophila, Pseudomonas fluorescens, and Pseudomonas syringae (31) . IpaH protein family members share structural and functional similarity; they are composed of an N-terminal leucinerich repeat (LRR) and a highly conserved C-terminal region (CTR) (33, 34) . The conserved CTR contains a Cys residue, which is critical for E3 ubiquitin ligase activity (31, 35, 36) . Each of the IpaH family effectors characterized to date (e.g., Shigella IpaH9.8 and IpaH2077, Salmonella SlrP, SspH1, and SspH2, Yersinia YopM, and Rhizobium Y4fR and BIpM) has distinct host protein targets in different host cell types. Some act as effectors to attenuate host inflammatory responses, whereas others modulate host defense responses in plants (37, 38) . The existence of multiple effectors with E3 ligase activity suggests that an array of E3 ligases is required to promote bacterial infection and antagonize host innate defense responses.
Fernandez-Prada et al. (39) previously reported that Shigella lacking the ipaH7.8 gene are less capable than the WT strain of escaping the phagocytic vacuole of macrophages and that Shigella infection of macrophages induces apoptotic-like cell death. Paetzold et al. (40) subsequently showed that Shigella lacking the ipaH7.8 gene had no effect on phagosome escape compared with the WT strain, but bacterial-induced cytotoxicity was low compared with that of the WT strain. Although the biological significance of IpaH7.8 as an E3 ubiquitin ligase during Shigella infection remains to be elucidated, these studies suggested that IpaH7.8 is involved in inducing macrophage cell death.
In this context we wished to clarify the pathological role of IpaH7.8 as an E3 ubiquitin ligase in Shigella infection of macrophages and the modality of cell death. Here we provide evidence that IpaH7.8 potentiates macrophage killing in an IpaH7.8 E3 ligase-dependent manner, in which E3 ligase activity triggers NLR inflammasome-mediated macrophage cell death by targeting glomulin/FAP68 (GLMN); this activity ultimately appears to benefit the pathogen.
Results
IpaH7.8 Activity Contributes to Bacterial Multiplication. Because inflammatory cell death in response to bacterial infection is an important part of the host immune defense mechanism (1-3, 26), we wished to investigate whether the secretion of IpaH7.8 during Shigella infection is beneficial to the bacteria. To this end, we infected BALB/c mice with Shigella via the intranasal route, which is a well-established model for evaluating Shigella pathogenesis (41) . BALB/c mice were infected intranasally with a sublethal dose of WT Shigella, an IpaH7.8 mutant (ΔipaH7.8), the IpaH7.8-complemented strains ΔipaH7.8/ipaH7.8 or ΔipaH7.8/ ipaH7.8CA (in which the Cys residue 357 was replaced with Ala) which lack putative E3 ligase activity, or the T3SS-deficient mutant strain S325. Lung bacterial load, inflammation, and IL-1β production were examined 24 h postinfection ( Fig. 1) . Infection with either ΔipaH7.8 or ΔipaH7.8/ipaH7.8CA produced lower levels of IL-1β in lung tissue than did infection with either WT or ΔipaH7.8/ipaH7.8 Shigella (Fig. 1A) . Although all strains induced an inflammatory response in the lung, the responses to WT and ΔipaH7.8/ipaH7.8 infections were much stronger than the responses to ΔipaH7.8, ΔipaH7.8/ipaH7.8CA, or S325 infections ( Fig. 1 A-C) . Notably, the lung bacterial loads were significantly higher in mice infected with WT or ΔipaH7.8/ipaH7.8 than in mice infected with ΔipaH7.8, ΔipaH7.8/ipaH7.8CA, or S325 Shigella (Fig. 1D) . Together, these results strongly suggested that IpaH7.8 E3 ligase-dependent intracellular activity benefits the pathogen by promoting infection.
Shigella IpaH7.8-Mediated Cell Death Is Macrophage Specific. We infected BALB/c bone marrow-derived macrophages (BMDMs) with WT, ΔipaH7.8, ΔipaH7.8/ipaH7.8, ΔipaH7.8/ipaH7.8CA, or S325 bacteria and assessed the ability of each bacterial strain to kill macrophages using the LDH assay. We confirmed that Shigella induce rapid macrophage cell swelling and lysis within 2 h through a T3SS-dependent mechanism (19, 39, 40) and determined that cell death occurred in an IpaH7.8-dependent manner ( Fig. 2A) . Under conditions in which there was a uniform number of bacteria in the cell cytosol (Fig. S1A ), IpaH7.8 activity was confined almost exclusively to peritoneal macrophages and to the macrophage cell lines J774A.1 and RAW264.7 ( Fig. 2A) but was not observed in HeLa cells, 293T cells, Jurkat T cells, or Raji B cells, suggesting that IpaH7.8-dependent cell death is specific to macrophages. That observation was consistent with previous macrophage studies by Fernandez-Prada et al. (39) and Paetzol et al. (40) . Because other Shigella IpaH E3 ligase effectors, e.g., IpaH9.8 and IpaH4.5, had no appreciable ability to induce rapid macrophage cell killing (Fig. S1B) , and because the observed IpaH7.8 activity was dependent on its E3 ligase activity ( Fig. 2A and Fig. S1B ), we concluded that IpaH7.8 is a key player in eliciting macrophage cell death during Shigella infection.
IpaH7.8-Dependent Cell Death Occurs Via Caspase-1 Activation. We determined that Shigella infection of macrophages caused rapid cell death in an IpaH7.8 E3 ligase-dependent manner. Previous studies showed that Shigella infection of BMDMs causes rapid cell death via inflammasome-mediated caspase-1 activation (19) . Therefore, we examined the cell death of BMDMs treated with z-VAD (a pan-caspase inhibitor), z-YVAD (a caspase-1 inhibitor), or z-DEVD (a caspase-3 inhibitor) upon infection with WT, ΔipaH7.8, ΔipaH7.8/ipaH7.8, or S325 Shigella for up to 3 h. IpaH7.8-dependent cell death decreased with z-VAD and z-YVAD treatment but not with z-DEVD treatment (Fig. S2A) , indicating that IpaH7.8-dependent macrophage cell death upon Shigella infection occurred mainly through caspase-1 activation.
To confirm these findings, we examined the effects of IpaH7.8 on caspase-1 activation and on IL-1β, IL-6, IL-18, and MIP-2 production by infecting BMDMs with WT, ΔipaH7.8, ΔipaH7.8/ ipaH7.8, ΔipaH7.8/ipaH7.8CA, or S325 Shigella for 1 h. Caspase-1 processing and production of IL-1β and IL-18, but not of IL-6 and IL-8/MIP-2, occurred in an IpaH7.8 E3 ligase-dependent manner ( Fig. 2 B and C) . To confirm further that caspase-1 activation was involved in this process, BMDMs isolated from caspase-1-KO or WT BALB/c mice were stimulated with LPS and subsequently infected with the various Shigella strains. As shown in Fig. 2D , IpaH7.8 E3 ligase-dependent BMDM cell death required capase-1 activity. Of note, the IpaH7.8-dependent death of BMDMs was markedly prevented by glycine treatment, which can block pyroptosis (Fig. S2B) . The effects of IpaH7.8 on IL-1β and IL-18 production also were confirmed in Shigellainfected human monocyte-derived macrophages (HMDMs) (Fig.  2E) . Together, these results strongly suggested that pyroptotic cell death occurs in an IpaH7.8 E3 ligase-dependent manner during Shigella infection.
IpaH7.8 E3 Ligase-Dependent Cell Death Occurs Through the Activation of the NLRP3 and NLRC4 Inflammasomes. It was shown previously that Shigella infection of macrophages stimulates the NLRP3 and NLRC4 inflammasomes and IL-1β production (8, 19) . Therefore we examined IpaH7.8 E3 ligase-dependent cell death upon Shigella infection using BMDMs from NLRC4-KO mice on a BALB/c background. Levels of LDH (Fig. S3B ) and the active form of caspase-1 (Fig. 2B and Fig. S3C ) were lower in BMDMs from NLRC4-KO mice infected with Shigella WT (or with ΔipaH7.8/ipaH7.8), but not with ΔipaH7.8 (ΔipaH7.8/ipaH7.8CA and S325), than in BMDMs from WT mice (Fig. S3 A-C) . Because NLRC4-KO mice are limited to the BALB/c background, we examined the effects of shRNA-mediated knockdown of NLRP3, NLRC4, or NLR family pyrin domain-containing 1b (NLRP1b) on IpaH7.8-dependent cell death during Shigella infection. As shown in Fig. 3A and Fig. S3D , knockdown of NLRP3 or NLRC4, but not of NLRP1b, reduced IL-1β production. Furthermore, when NLRP3 was knocked down in BMDMs from NLRC4-KO mice, the IL-1β levels stimulated by IpaH7.8 were decreased further (Fig. 3A and Fig. S3D ). We subsequently examined whether IpaH7.8 E3 ligase activity is required to stimulate inflammasome and caspase-1 activation using HEK293T cells transfected with combinations of T7-NLRP3 Fig. 3 . IpaH7.8 E3 ubiquitin ligase-dependent cell death occurs via activation of the NLRP3 and NLRC4 inflammasomes. IpaH7.8 induces NLRP3 and NLRC4 activation followed by IL-1β maturation in macrophages. (A) shRNA-mediated knockdown of NLRP3, NLRC4, and NLRP1b. BMDMs from BALB/c WT mice or BALB/c NLRC4-KO mice were infected with pLKO.1 lentivirus expressing shRNA directed against NLRP3, NLRC4, or NLRP1b. A lentivirus carrying the empty pLKO.1 vector was used as a negative control. NLRP3/NLRC4/NLRP1b silencing was assessed (Fig. S3D) ; then the cells were infected with the indicated Shigella strains (MOI of 10) for 2 h and examined for IL-1β production. (or HA-NLRC4), T7-ASC, HA-caspase-1, FLAG-IL-1β, and GFP-IpaH7.8 (or GFP-IpaH7.8CA). The results showed that IpaH7.8, but not IpaH7.8CA, could stimulate both inflammasomes and induce mature IL-1β production in an E3 ligase activitydependent manner (Fig. 3B) . Consistent with these results, macrophages infected with Shigella producing IpaH7.8CA had a reduced ability to induce mature IL-1β production and cell death (Figs. 1A  and 2 ). The diminished effects of IpaH7.8CA-expressing Shigella also were confirmed in a mouse model (Fig. 1) . Because recent studies have shown that inflammasome-dependent caspase-1 activation can be inhibited by treating cells with proteasome inhibitors (42-44), we assessed IpaH7.8-dependent macrophage cell death in macrophages treated or not treated with MG132, a ubiquitin-proteasome inhibitor. As shown in Fig. S3E , the IpaH7.8-dependent cell-death response was abolished almost completely in MG132-treated cells (Fig. S3E) . Based on these results, we concluded that IpaH7.8 E3 ligase activity is a critical factor in inducing macrophage cell death during Shigella infection.
GLMN Is an IpaH7.8 Target. These results strongly suggested that Shigella-induced macrophage cell death depends on IpaH7.8 E3 ligase activity. Thus, we hypothesized that the IpaH7.8 E3 ligase targets some host factor(s) that undergoes IpaH7.8 E3 ligasemediated ubiquitination and participates in the inflammasomecaspase-1 cell-death pathway. To identify these potential targets, we screened for host proteins that interacted with IpaH7.8 (the IpaH7.8 CA mutant was used to minimize targeting of host protein degradation) in a yeast two-hybrid assay using a mouse brain library and identified two potential hits, GLMN (Fig. S4 A  and B) and filamin A. Because siRNA-mediated knockdown of filamin A had no effect on macrophage cell death in response to Shigella infection, we investigated GLMN as an IpaH7.8-binding partner and found that GLMN interacted predominantly with the LRR domain of IpaH7.8 (Fig. 4A) . GLMN originally was identified as a gene responsible for familial glomuvenous malformations, a disorder that results in localized cutaneous vascular lesions because of loss-of-function mutations in the Glmn gene (45) (46) (47) (48) . More recently, GLMN was characterized as a Cullin ring ligase inhibitor that blocks interaction with its ubiquitin-conjugating enzyme (E2) (49, 50) . First, we confirmed the interaction between GLMN and IpaH7.8 (and IpaH7.8CA) in a GST pull-down assay (Fig. 4A) . To examine this interaction further, we created a series of truncated GLMN mutants and examined their capacity to interact with IpaH7.8 using a GST-IpaH7.8 pull-down assay. As shown in Fig.  S4 C and D, ∼55 amino acids in the GLMN N-terminal domain mediated the interaction with IpaH7.8. Immunohistochemical analyses of macrophage cells expressing T7-IpaH7.8 revealed that IpaH7.8 colocalized with GLMN in the cytoplasm (Fig. 4B) . Because IpaH7.8 E3 ligase activity is involved in inflammasome activation during Shigella infection, we investigated whether GLMN underwent IpaH7.8 E3 ligase-dependent degradation. To this end, HEK293T cells were transfected with GFP-IpaH7.8 (or GFP-IpaH7.8CA or GFP mock) and then examined the levels of endogenous GLMN. The GLMN levels were lower in cells transfected with full-length IpaH7.8 than in cells transfected with IpaH7.8CA or the GFP mock control (Fig. S4E) . A cycloheximide chase assay using HEK293T cells that were transfected with GFP-IpaH7.8 (or GFP-IpaH7.8CA) confirmed that endogenous GLMN levels decreased in the presence of IpaH7.8, but not IpaH7.8CA, although IpaH7.8 was expressed at lower levels than IpaH7.8CA because of its inherent E3 ligase activity (Fig. 4C ). In addition, as shown in Fig. 4D , the decrease in endogenous GLMN in Shigella-infected BMDMs was prevented by MG132 treatment, which blocks proteasome activity. Furthermore, using an in vitro E3 ligase activity assay with purified E1, E2 (UbcH5B), E3 (IpaH7.8 or IpaH7.8CA), and GLMN, we demonstrated that IpaH7.8, but not IpaH7.8CA, ubiquitinates GLMN and IpaH7.8 itself (Fig. 4E) . We further examined the cellular distribution of GLMN in macrophages infected with WT, ΔipaH7.8, ΔipaH7.8/ipaH7.8, ΔipaH7.8/ipaH7.8CA, or S325 Shigella. When cells were infected with these bacterial strains, the cytoplasmic GLMN signal decreased as GLMN formed puncta in an IpaH7.8-dependent manner (Fig. 4 F and G) . These results strongly suggested that GLMN undergoes proteasomedependent degradation in an IpaH7.8 E3 ubiquitin ligasedependent manner.
GLMN Is Functionally Involved in Inflammasome Activation. To ensure the functional involvement of GLMN in IpaH7.8-mediated inflammasome activation, we investigated the effects of GLMN on NLRP3 inflammasome activation in macrophages treated with LPS and ATP, well-known NLRP3 agonists (1, 2, 7). As shown in Fig. 5A and Fig. S5 , in quiescent cells, endogenous GLMN was dispersed throughout the macrophage cytoplasm and nuclei. Upon stimulation of the inflammasome with LPS/ATP, GLMN relocalized into punctate structures ( Fig. 5A and Fig. S5 ). Importantly, Shigella infection also induced the formation of GLMN-containing puncta in an IpaH7.8 E3 ligase-dependent manner (Fig. 4 F and G) . Under these conditions, GLMN puncta (red in Fig. 5A ) occasionally colocalized with the active form of caspase-1 (green in Fig. 5A ). To determine whether GLMN levels could affect IL-1β production, siRNA-mediated knockdown of GLMN was performed in HEK293T cells transfected with T7-NLRP3 (or HA-NLRC4), T7-ASC, HA-caspase-1, or FLAG-IL-1β for 48 h. As shown in Fig. 5B , IL-1β levels were higher in cells treated with anti-GLMN siRNA than in cells treated with the control (Fig. 5B) . Together, these data suggested that GLMN puncta associate with the inflammasome. To test this notion, we investigated the effects of GLMN overexpression on inflammasome activation, cell death, and IL-1β maturation. Upon GLMN overexpression, the degree of macrophage cell death after 2 h of LPS/ATP treatment was less than half of that detected in the control, as determined by the LDH assay (Fig. 5C) . Similarly, the levels of mature IL-1β in GLMNoverexpressing cells after 1.5 or 2 h of LPS/ATP treatment were ∼40% lower than in the control (Fig. 5C and Fig. S6A ). Consistent with these results, GLMN showed striking cytoprotective and anti-inflammatory effects when macrophages overexpressing GLMN were infected with WT Shigella, but not with the ΔipaH7.8 mutant (Fig. 5D) . Together, these results strongly suggested that GLMN functionally correlates with inflammasome activation in macrophages during Shigella infection.
GLMN Dampens Inflammasome Activation and Macrophage Pyroptosis.
In the above context, we wished to establish the biological involvement of GLMN in modulating inflammasome activity. To this end, we created GLMN-null or GLMN-heterozygous mice on a BALB/c background ( Fig. S6 B and C) . Consistent with findings in other studies (50) , GLMN +/− mice were healthy, fertile, and had no visible disorders, whereas GLMN −/− embryos at embryonic day (E)7.5-E10.5 were fleshy masses that did not undergo further development. Therefore, we examined Shigellainduced cytotoxicity and IL-1β secretion in BMDMs from GLMN +/− and GLMN +/+ mice. An intranasal Shigella infection study in GLMN +/+ and GLMN +/− mice indicated that GLMN
animals produced higher levels of tissue IL-1β ( Fig. 6A ) and produced a stronger inflammatory response than GLMN +/+ animals (Fig. 6B) . Surprisingly, bacterial loads in the lung were remarkably higher in GLMN +/− mice (Fig. 6C ). As shown in Fig. 6 D and E, upon LPS/ATP stimulation or Shigella infection, the levels of cytotoxicity and IL-1β secretion increased up to twofold in BMDMs from GLMN +/− mice compared with those from GLMN +/+ mice. Furthermore, siRNA-mediated knockdown of GLMN in GLMN +/− BMDMs promoted cell cytotoxicity and IL-1β secretion (Fig. 6 F and G and Fig. S6D ). These results were consistent with the hypothesis that the level of GLMN in macrophages influences inflammasome activation.
Discussion
In this study, we identified a unique stratagem whereby which bacteria manipulate macrophage cell death by stimulating inflammasome-caspase-1-mediated cell death (Fig. 7) . We determined that the Shigella IpaH7.8 E3 ubiquitin ligase effector executed rapid cell death by activating the NLRP3 and NLRC4 inflammasomes, leading to caspase-1-dependent pyroptosis. Intriguingly, the mechanism by which IpaH7.8 induced macrophage cell death did not seem to involve the direct targeting of inflammasome components. Instead, it was likely exerted via IpaH7.8 E3 ligase-mediated proteasome-dependent GLMN degradation. Because macrophage death during Shigella infection is a prerequisite for facilitating bacterial egression from macrophages and subsequent bacterial invasion of epithelial cells (26, 51) , it is likely the IpaH7.8-mediated stimulation of pyroptosis via NLR inflammasome activation is an important Shigella stratagem to promote bacterial multiplication.
We showed that Shigella induced rapid macrophage cell death, within 2-3 h, which was strongly dependent upon IpaH7.8 E3 ligase activity. Indeed, experiments in which mice were infected intranasally with Shigella demonstrated that infection by a Shigella strain lacking the ipaH7.8 gene (ΔipaH7.8) or by a strain lacking the E3 ligase activity (ΔipaH7.8/ipaH7.8CA) resulted in a lower inflammatory response than produced by infection with WT Shigella; furthermore, the multiplication rate of ΔipaH7.8 was greatly reduced compared with WT ( Fig. 1 C and D) . Therefore we assume that IpaH7.8-induced inflammasome-mediated macrophage cell death is more beneficial to the pathogen than the host.
In the present study, we identified GLMN as an IpaH7.8-binding partner in yeast-two hybrid and GST pull-down assays and determined that the interplay between IpaH7.8 and GLMN is functionally important for stimulating inflammasome-mediated cell death during Shigella infection. Indeed, using an in vitro ubiquitin assay, we found that GLMN is polyubiquitinated in the presence of IpaH7.8 but not in the presence of the IpaH7.8-CA (E3 ligase activity-deficient) mutant, suggesting that GLMN degradation occurred in an IpaH7.8 E3 ligase-dependent manner. Intriguingly, GLMN seems to have some cytoprotective activity against macrophage cell death that is induced by NLR inflammasome activation. For example, when GLMN was overexpressed, the levels of cell death in response to LPS/ATP treatment or IpaH7.8 production were much lower than those observed in the control (Fig. 5A) . Furthermore, NLRP3 inflammasome activation in macrophages upon LPS/ATP stimulation or Shigella infection resulted in the formation of GLMN puncta, which occasionally colocalized with the active form of caspase-1 (Fig.  5A) . Based on these results, we speculate that GLMN has the Fig. 7 . A proposed model for IpaH7.8-induced inflammasome activation. As a Shigella IpaH7.8 target, GLMN undergoes IpaH7.8 E3 ligase-dependent proteolysis, resulting in NLRP3 and NLRC4 inflammasome activation and pyroptosis. GLMN may interact with NLRP3 or NLRC4 via an unknown host factor (here designated "X"). The Shigella T3SS needle protein MxiH and rod component MxiI activate the NLRC4 inflammasome via hNAIP/mNAIP1 (21) and NAIP2 (20) , respectively. potential to modulate inflammasome activation either directly or indirectly.
GLMN previously was identified as a protein associated with the C terminus of Cul7, a member of the cullin family (47) . Cullins are subunits of the cullin RING ligase (CRL) family. The same group recently reported that GLMN binds directly to the RING domain of Rbx1 and inhibits its E3 ubiquitin ligase activity (49, 50) . Rbx1 regulates the cullin RING ligase-mediated turnover of Fbw7, a substrate receptor for Cul1-RING-CRL, which facilitates the ubiquitination and degradation of cyclin E and c-Myc (49, 50) . If this activity also is involved in the GLMN-inflammasome interplay, GLMN may suppress NLR inflammasome activation, e.g., by interacting with and inhibiting a hypothetical E3 ubiquitin ligase that activates the inflammasome. Our current effort is directed toward identifying the host factor(s) that mediate the relationship between GLMN and the inflammasome.
Although further studies are required to understand how GLMN modulates inflammasome activation, the IpaH7.8-GLMN interaction may represent a previously unidentified mechanism by which NLR inflammasomes are negatively controlled. If our premise is correct, it is tempting to speculate that IpaH7.8 may mimic an as yet uncharacterized host E3 ubiquitin ligase that stimulates NLR inflammasome activity by inducing the proteasomal degradation of GLMN. If this previously unidentified function of GLMN in controlling NLRP3 and NLRC4 inflammasome activation is central to humans, GLMN may be a potential therapeutic target that could be used to modulate inflammasome-related illnesses.
Materials and Methods
Primers used in this study are listed in Table S1 .
Shigella Strains and Plasmids. S. flexneri strain YSH6000 (52) was used as the WT strain, and S325 (mxiA::Tn5) (53) was used as the T3SS-deficient negative control. The Ipa7.8-deficient strain ΔipaH7.8 was constructed using allele replacement as previously described (54) . The IpaH7.8CA strain was created with a QuikChange site-directed mutagenesis kit (Stratagene). The pBluescriptII vector (Stratagene) or pCACTUS vector was used to construct the IpaH7.8-or IpaH7.8CA-overexpressing or genome complement strains. The WT Salmonella enterica serovar Typhimurium SR-11 v3181 and the isogenic fliA::Tn10 were provided by H. Matsui (Kitasato Institute for Life Science, Tokyo, Japan) (55).
Bacterial Infection. Shigella strains were precultured overnight in MuellerHinton broth (Difco) at 30°C. Bacterial cultures were inoculated into brain heart infusion broth (Difco) and incubated for 2 h at 37°C before infection. Macrophages were stimulated with or without 1 μg/mL LPS for 6 h and then were infected with Shigella. Cells were seeded in 24-well plates at a density of 5 × 10 5 cells per well. The cells were infected with Shigella at an MOI of 10. The plates were centrifuged at 700 × g for 10 min to synchronize the infection, and gentamicin (100 μg/mL) and kanamycin (60 μg/mL) were added after 20 min. At the indicated times postinfection, the LDH activity in the culture supernatants of infected cells was measured using the CytoTox 96 assay kit (Promega) according to the manufacturer's protocol. For immunofluorescence studies, the infected cells were fixed and immunostained and then were analyzed with a confocal laser-scanning microscope (LSM510; Carl Zeiss). Cytokine production in the culture supernatants was measured with an ELISA kit (R&D Systems). Experiments were repeated three times.
Statistical Analyses. Statistical analyses were performed using the MannWhitney u test. Differences were considered significant at P < 0.05.
